Nathan Brown and Marlee Gallant Discuss Top FDA Issues for Hospitals and Health Systems in Bloomberg BNA Article
Nathan Brown and Marlee Gallant, partner and associate, respectively, in Akin Gump’s health care and life sciences practice, have written the article “Top FDA Issues for Hospitals and Health Systems,” which was published by Bloomberg BNA’s Health Law Reporter.
The article notes that amid the rapid pace of innovation in medical technology, hospitals and health systems are increasingly engaged in activities regulated by the Food and Drug Administration (FDA). Brown and Gallant write that new laws implemented the FDA carry both opportunities and risks, and they identify five top FDA issues that health care facility managers, compliance officials and lawyers should consider this year.
To read the full article, please click here.